Positron emission tomography (PET) drugs, pipelines and market

Positron emission tomography (PET) drugs, pipelines and market

Positron emission tomography (PET) is a nuclear medicine imaging technique that produces a three-dimensional image or picture of functional processes in the body. Drugs Used to Treat Positron Emission Tomography Imaging

Common isotopes used in PET drugs

drug namegeneric namediagnosecompanystructureyear
Amyvidflorbetapir F 18Alzheimer’s diseaseAvid Radiopharmaceuticals/Eli Lilly 2011
NeuraCeqFlorbetaben (18F)Alzheimer’s diseaseLIFE MOLECULAR 2014
AMYViDflorbetapir F 18 Alzheimer’s diseaseAvid Radiopharmaceuticals/Eli Lilly 2011
Vizamylflutemetamol f-18Alzheimer’s diseaseGE healthcare 2014
Tauvidflortaucipir F 18Alzheimer’s diseaseAvid Radiopharmaceuticals/Eli Lilly 2020
Ceriannafluoroestradiol F18breast cancerZionexa USA 2020
Cardiogen-82Rubidium-82 chlorideheart diseaseBracco Diagnostics 82RbCl1989
NETSPOTgallium ga 68 dotatateneuroendocrine tumorsAdvanced Accelerator Applications USA, 2016
GALLIUM DOTATOC GA 68gallium ga-68 dotatocneuroendocrine tumors UIHC  2019
AxuminFluciclovine (18F)prostate cancerBlue Earth Diagnostics, Ltd., United Kingdom 2016
choline c-112-hydroxyethyl-dimethyl-(111C)methylamoniumprostate cancerMayo Clinic  2012
Ruby-Fill82RbClregional myocardial perfusionJUBILANT DRAXIMAGE82RbCl2016
Fludeoxyglucose F 18 Fludeoxyglucose F 18 assessment of glucose metabolism,imaging tumors,Alzheimer’s disease.multiple 1976